Impact of Primary Language on Treatment and Outcomes in Inflammatory Bowel Disease

The University of Texas System (UT)

Status: Not yet enrolling

Conditions: Inflammatory Bowel Disease

Treatments: Other: NO INTERVENTION

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT06405503

STUDY00004331

Details and patient eligibility

About

A thorough discussion of treatment options to manage inflammatory bowel disease (IBD), including the risks and benefits of each class of medication, can be a complex discussion and time consuming. Having to use a translator adds an additional layer of time and complexity to these discussions as well as potential misunderstanding. Further, in addition to language, cultural differences can also play into treatment acceptance.

This study aims to determine the impact of primary language on the selection of treatment for IBD and on disease outcomes.

Enrollment: 206 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥18 years of age
• Confirmed diagnosis of IBD (CD, UC or indeterminate colitis)
• Willing to provide consent for participation
• Managed at an outpatient clinic either the Yale New Haven Hospital system or the University of Texas at Austin Hospital system.

Exclusion criteria

• Patients <18
• No confirmed diagnosis of IBD
• Not planning to continue care at either study site (i.e. presenting for a consultation only)
• Unwilling to provide signed consent

Trial design

206 participants in 2 patient groups

English as primary language

Treatment:

Other: NO INTERVENTION

Non-English as primary language

Treatment:

Other: NO INTERVENTION